Simultaneous defeat of MCF7 and MDA-MB-231 resistances by a hypericin PDT-tamoxifen hybrid therapy
Theodossiou TA, Ali M, Grigalavicius M, Grallert B, Dillard P, Schink KO, Olsen CE, Wälchli S, Inderberg EM, Kubin A, Peng Q and Berg K. NPJ Breast Cancer 5: 13 (2019).
Published Aug. 5, 2019 9:37 AM
- Last modified Aug. 5, 2019 9:37 AM